← All Wire coverage

Situationmaterial

FDA clears C2N Diagnostics' PrecivityAD2 blood test for Alzheimer's diagnosis in adults aged 40+

Carried more widely than almost anything else in the last 30 days

Reports

11

Domains carrying it

11

First reported

20 August 2026

Latest report

4 September 2026

Sectors

Digital Health

Where

United States

Timeline

  1. 20 August 2026FDA clears C2N Diagnostics' PrecivityAD2 blood test for Alzheimer's diagnosis in adults aged 40+app.dealroom.co
  2. 21 August 2026FDA Clears PrecivityAD2 Blood Test for Alzheimer's in Adults as Young as 40clinicaltrialvanguard.com
  3. 22 August 2026FDA clears blood test to aid evaluation for Alzheimer's diseaseeurekalert.org
  4. 24 August 2026FDA-Cleared Alzheimer's Blood Test Marks a Shift Toward Earlier, Less Invasive Diagnosisinsideprecisionmedicine.com
  5. 4 September 2026New Blood Test for Alzheimer's Gets FDA Clearance—Here's How It Worksnewsweek.com

Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

Share